Mr. Bernard Siegel

Stem Cell and Cloning Ethics and Public Policy

A variety of articles on Bernie Siegel’s efforts as a lawyer and stem cell advocate. Such as proving Clonaid’s ‘Cloned’ baby is a sham, and convincing the UN not to ban cloning outright.

Exerpts from the 2010 Report from the World Stem Cell Summit.

Bellantoni 2010. Stem cell research plaintiffs fight for personal beliefs, win on financial grounds. Talking Points Memo.

Question 1

Mr. Siegel can you please tell us a bit about yourself, your career path over the years and how it has led you to become one of the most prevalent advocates for stem cell research and cloning?

Michael Barresi

Question 2

Could you speak a little to the differences between therapeutic and reproductive cloning? What are the ethical concerns associated with each category?

Ken Tanaka

Follow-up: In 2003, you lead a group of world-class researchers on stem cells going against an international treaty to ban nuclear transfer research. Your reason was that the cloned cells would never be implanted in a woman’s womb, and therefore it would biologically impossible to become a human. Could you please comment on that (for documentary purposes)?

Gwen Huynh

Question 3

Dr. Theresa Deisher has referred to the potential of the embryonic stem cell researches as being similar to a ”’nebulous promise’ of constructing Martian housing”. What do you think about her statement? What do you think about the difference, similarity, importance, and the relationship between the effective and affordable adult stem cell and the embryonic stem cells that has ‘nebulous promise’?

Hyunwon (Sylvie) Bae

Question 4

Could you please describe for us the context and particular specifics that represent the lawsuit Drs. Deisher and Sherley have brought up against the federal government? For instance, what exactly is their argument? Is there basis to their competition claims? What is the Dicky Wiker amendment?

Follow-up: If the court, by any chance, rules in favor Drs. Deisher and Sherley in their current court case, what measures would the Genetics Policy Institute take? Do you see any possibility of this happening?

Carla M. Vélez

Question 5

Do you see way to get the ethical debates about the embryonic stem cell research settled down? Can you think of any plausible solution or conclusion to this debate that some people view as a life and death imperative? Who do you think should play a key role to decide on this matter? Alternatively, do you think that the significant opposition against cloning and the use of human embryonic stem cells will simply fade away as increasingly favorable medical results are discovered such as in the ongoing Geron clinical trials? In other words will this debate ultimately be settled in the lab and bedside rather then in the courts?

Hyunwon (Sylvie) Bae

Question 6

Do you feel as if the Clonaid claim set ESC research back at all?

Rachael Stein, read by Christina Wright

Question 7

You’ve mentioned that you seek to be a voice for both patients and scientists. How do you balance promoting enthusiasm and support for stem cell research with patient’s hopes for cures within their lifetimes?

Sean McGill

Question 8

Could you compare and contrast the current state of affairs in the United States with other countries in terms of handling these policy issues?

Michael Barresi

Question 9

Can you share with us examples of individuals you have encountered who have reached a dead end in terms of treatment and prognosis? And exactly which of the current developments in stem cell research you think may help them?

Saira Huq

Question 10

Currently in your opinion what are the most difficult obstacles to the progress of stem cell research and what will you and the Gentics Policy Institute do to overcome these obstacles?

Michael Barresi